“If you’re comfortable talking about it with trusted friends or family members, getting a referral from someone you trust and ...

The Alzheimer's Association revised the diagnostic criteria for Alzheimer disease (AD) and ADRD for clinicians in primary and specialty care.

After SPN-820's failure, Supernus is relying on its non-stimulant ADHD drug Qelbree and the recently approved Parkinson’s ...

You can add it to your coffee, cook it fresh or pop as a pill – but does this popular mushroom actually supercharge your ...

The phase IIb study results of Supernus Pharmaceuticals Inc.’s SPN-820 in treatment-resistant depression had pulled the company’s stock (NASDAQ:SUPN) down 15.6% on Feb. 19. The randomized, ...

The company announced on 18 February that the trial did not meet its primary endpoint measured by a depression rating scale, ...

Supernus' SPN-820 Phase 2b study in treatment-resistant depression failed to meet its primary endpoint, prompting further ...

Supernus Pharmaceuticals said on Tuesday its depression treatment trial failed to meet the main goal of reduction in depressive symptoms, sending its shares down 22% aftermarket.

Psychosocial breastfeeding support interventions may prevent some cases of postpartum (postnatal) depression in mothers one to three months after the support has been received and increase the ...